Identification of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil, using a sensitive/less-sensitive assay: An update [4]

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 3, 2004, Pages 880-881

  Barroso, Paulo Feijó ^a   Harrison, Lee H ^b   De Fátima Melo, Maria ^a   Batista, Sônia Maria ^a   Da Silva Bastos, Marilene ^a   Da Rosa Faulhaber, José Claudio ^a   Moreira, Ronaldo Ismério ^a   Do Lago, Regina Ferro ^a   Schechter, Mauro ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; BRAZIL; COHORT ANALYSIS; DRUG EFFICACY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HETEROSEXUALITY; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LETTER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEROLOGY;

EID: 3042857752     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200407010-00019     Document Type: Letter

References (2)

1. Janssen RS, Satten GA, Stramer S, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42-48.
2. Schechter M, Lago RF, Melo MF, et al. Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr. 2000;24:175-177.